Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Mallinckrodt plc (MNK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Quarterly results
08/23/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "LATHAM & WATKINS LLP",
"W I T N E S S E T H:",
"RECITALS",
"Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan",
"Recommendation by the Debtors and RELATED SUPPORT",
"CONFIDENTIAL – MATERIAL NON-PUBLIC INFORMATION SUBJECT TO FRE 408, STATE LAW EQUIVALENTS Disclaimer 2 Statements in this document that are not strictly historical, including statements regarding future financial condition and operating results, legal, economic, business, competitive and/or regulatory factors affecting Mallinckrodt plc’s businesses, and any other statements regarding events or developments Mallinckrodt believes or anticipates will or may occur in the future, may be “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, and involve a number of risks and uncertainties. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-look..."
08/15/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Amendment to Forbearance Agreement",
"Amendment to Forbearance Agreement",
"Amendment to Forbearance Agreement",
"Amendment to Forbearance Agreement"
08/09/2023 8-K Quarterly results
Docs: "Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year Guidance Reports Second Quarter Net Sales of $475.0 Million, Reflecting a 1.3% Growth on a Reported and Constant Currency Basis Compared to the Prior Year Quarter"
07/17/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
07/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Exhibit 10.1"
07/06/2023 8-K Other Events  Interactive Data
06/30/2023 8-K Other Events  Interactive Data
06/16/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AMENDMENT NO. 1 TO OPIOID DEFERRED CASH PAYMENTS AGREEMENT"
05/09/2023 8-K Quarterly results
Docs: "Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year Guidance Advanced Launch of Terlivaz® with Rapid and Successful Uptake in Hospital Formulary Access and Continued Medical Community Interest"
03/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "1900 S 1940 S 1980 S 2000 S 2022"
02/28/2023 8-K Quarterly results
12/08/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
Docs: "Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance Launched Terlivaz® Following U.S. Food and Drug Administration Approval in September&#59; Submitted U.S. FDA Premarket Notification Application for Next-Generation Delivery System of INOmax®"
10/24/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
09/29/2022 8-K Quarterly results
09/15/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Media Inquiries"
08/22/2022 8-K Quarterly results
08/17/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
07/21/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
06/22/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/03/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
05/03/2022 8-K Bankruptcy or Receivership, Financial Statements and Exhibits  Interactive Data
Docs: "Fourth Amended Joint Plan of Reorganization (with Technical Modifications) of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (included as Schedule 2 to the Order of the High Court of Ireland, dated as of April 27, 2022)",
"Amended Proposals for a Scheme of Arrangement Between Mallinckrodt Public Limited Company and Its Members and Creditors (included as Schedule 1 to the Order of the High Court of Ireland, dated as of April 27, 2022)",
"Order of the High Court of Ireland"
04/20/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Mallinckrodt Pharmaceuticals Preliminary Q1 2022 Results for Lender Presentation",
"Mallinckrodt Pharmaceuticals Preliminary Q1 2022 Results for Lender Presentation"
04/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Mallinckrodt Pharmaceuticals Lender Presentation",
"Mallinckrodt Pharmaceuticals Lender Presentation"
03/15/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Three Months Ended 1"
03/11/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
02/14/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Independent Experts Report"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy